BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 20.18 Million DKK | -10.89% |
| 2022 | 19.04 Million DKK | 26.6% |
| 2021 | 15.04 Million DKK | 12.76% |
| 2020 | 13.33 Million DKK | -23.02% |
| 2019 | 17.32 Million DKK | -2.84% |
| 2018 | 17.83 Million DKK | -2.26% |
| 2017 | 18.24 Million DKK | 16.28% |
| 2016 | 15.69 Million DKK | 1.37% |
| 2015 | 15.48 Million DKK | 17.3% |
| 2014 | 13.19 Million DKK | 45.95% |
| 2013 | 9.04 Million DKK | -18.2% |
| 2012 | 11.05 Million DKK | 5.09% |
| 2011 | 10.52 Million DKK | 24.38% |
| 2010 | 8.45 Million DKK | 35.16% |
| 2009 | 6.25 Million DKK | 68.32% |
| 2008 | 3.71 Million DKK | 0.0% |
| 2007 | 3.71 Million DKK | 18.63% |
| 2006 | 3.13 Million DKK | 2647.97% |
| 2005 | -123 Thousand DKK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 6.98 Million DKK | -2.61% |
| 2024 Q1 | 7.17 Million DKK | 87.99% |
| 2023 Q2 | 4.96 Million DKK | -6.46% |
| 2023 Q4 | 3.81 Million DKK | -37.42% |
| 2023 Q3 | 6.09 Million DKK | 22.76% |
| 2023 Q1 | 5.3 Million DKK | 9.74% |
| 2023 FY | 16.96 Million DKK | -10.89% |
| 2022 Q4 | 4.83 Million DKK | 14.98% |
| 2022 FY | 19.04 Million DKK | 26.6% |
| 2022 Q1 | 3.94 Million DKK | 15.11% |
| 2022 Q2 | 6.05 Million DKK | 53.37% |
| 2022 Q3 | 4.2 Million DKK | -30.49% |
| 2021 Q4 | 3.42 Million DKK | -11.85% |
| 2021 FY | 15.04 Million DKK | 12.76% |
| 2021 Q1 | 3.18 Million DKK | -12.96% |
| 2021 Q2 | 4.53 Million DKK | 42.21% |
| 2021 Q3 | 3.88 Million DKK | -14.24% |
| 2020 Q3 | 2.99 Million DKK | -30.85% |
| 2020 Q1 | 2.35 Million DKK | -42.79% |
| 2020 FY | 13.33 Million DKK | -23.02% |
| 2020 Q2 | 4.32 Million DKK | 83.66% |
| 2020 Q4 | 3.66 Million DKK | 22.46% |
| 2019 Q2 | 5.19 Million DKK | 57.44% |
| 2019 Q4 | 4.11 Million DKK | -12.72% |
| 2019 Q3 | 4.71 Million DKK | -9.16% |
| 2019 FY | 17.32 Million DKK | -2.84% |
| 2019 Q1 | 3.29 Million DKK | -48.02% |
| 2018 Q4 | 6.34 Million DKK | 92.8% |
| 2018 FY | 17.83 Million DKK | -2.26% |
| 2018 Q1 | 3.2 Million DKK | -35.12% |
| 2018 Q2 | 4.98 Million DKK | 55.41% |
| 2018 Q3 | 3.29 Million DKK | -33.99% |
| 2017 Q1 | 4.15 Million DKK | -17.77% |
| 2017 Q4 | 4.94 Million DKK | 16.73% |
| 2017 Q3 | 4.23 Million DKK | -13.67% |
| 2017 FY | 18.24 Million DKK | 16.28% |
| 2017 Q2 | 4.9 Million DKK | 18.09% |
| 2016 Q4 | 5.05 Million DKK | 57.79% |
| 2016 FY | 15.69 Million DKK | 1.37% |
| 2016 Q1 | 3.88 Million DKK | -14.34% |
| 2016 Q2 | 3.55 Million DKK | -8.6% |
| 2016 Q3 | 3.2 Million DKK | -9.77% |
| 2015 Q1 | 2.69 Million DKK | -22.93% |
| 2015 Q3 | 3.71 Million DKK | -18.2% |
| 2015 Q4 | 4.53 Million DKK | 22.11% |
| 2015 Q2 | 4.53 Million DKK | 68.42% |
| 2015 FY | 15.48 Million DKK | 17.3% |
| 2014 Q1 | 3.18 Million DKK | 77.0% |
| 2014 FY | 13.19 Million DKK | 45.95% |
| 2014 Q3 | 3.42 Million DKK | 11.11% |
| 2014 Q4 | 3.49 Million DKK | 1.98% |
| 2014 Q2 | 3.08 Million DKK | -3.14% |
| 2013 Q1 | 1.31 Million DKK | -57.63% |
| 2013 FY | 9.04 Million DKK | -18.2% |
| 2013 Q3 | 3.41 Million DKK | 35.45% |
| 2013 Q4 | 1.8 Million DKK | -47.25% |
| 2013 Q2 | 2.51 Million DKK | 92.14% |
| 2012 Q4 | 3.09 Million DKK | 9.83% |
| 2012 Q2 | 1.94 Million DKK | -39.45% |
| 2012 Q1 | 3.2 Million DKK | 26.04% |
| 2012 Q3 | 2.81 Million DKK | 45.21% |
| 2012 FY | 11.05 Million DKK | 5.09% |
| 2011 Q1 | 4.36 Million DKK | 105.46% |
| 2011 Q3 | 2.27 Million DKK | 47.6% |
| 2011 Q4 | 2.54 Million DKK | 11.83% |
| 2011 FY | 10.52 Million DKK | 24.38% |
| 2011 Q2 | 1.54 Million DKK | -64.71% |
| 2010 Q2 | 2.06 Million DKK | -1.48% |
| 2010 Q4 | 2.12 Million DKK | -2.12% |
| 2010 Q3 | 2.17 Million DKK | 4.98% |
| 2010 FY | 8.45 Million DKK | 35.16% |
| 2010 Q1 | 2.09 Million DKK | 38.48% |
| 2009 Q3 | 1.82 Million DKK | 37.62% |
| 2009 Q1 | 1.58 Million DKK | 0.0% |
| 2009 FY | 6.25 Million DKK | 68.32% |
| 2009 Q4 | 1.51 Million DKK | -17.17% |
| 2009 Q2 | 1.32 Million DKK | -16.15% |
| 2008 FY | 3.71 Million DKK | 0.0% |
| 2007 FY | 3.71 Million DKK | 18.63% |
| 2006 FY | 3.13 Million DKK | 2647.97% |
| 2005 FY | -123 Thousand DKK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 10556.995% |
| Arrayit Corporation | 2.57 Million USD | -683.749% |
| Atlantic International Corp. | -154.23 Thousand USD | 13185.312% |
| Biocept, Inc. | -2.58 Million USD | 881.642% |
| Bioqual, Inc. | 7.42 Million USD | -171.66% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -7212.319% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.701% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -1024.918% |
| iMD Companies, Inc. | -23.63 Thousand USD | 85483.086% |
| IDenta Corp. | 662.97 Thousand USD | -2944.157% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 12.416% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -25917.455% |
| InVitro International | 635.98 Thousand USD | -3073.345% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -207.512% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -1747.012% |
| NovelStem International Corp. | 12 Thousand USD | -168083.333% |
| Optigenex Inc. | -102.96 Thousand USD | 19700.645% |
| PharmChem, Inc. | 3.9 Million USD | -416.907% |
| Proteome Sciences plc | 2.09 Million USD | -862.592% |
| Response Genetics, Inc | 3.94 Million USD | -411.974% |
| Rennova Health, Inc. | 6.26 Million USD | -221.972% |
| RushNet, Inc. | 1.1 Million USD | -1727.062% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -2256.13% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 5098.675% |
| Todos Medical Ltd. | 4.31 Million USD | -368.26% |